JPH0456807B2 - - Google Patents
Info
- Publication number
- JPH0456807B2 JPH0456807B2 JP59280689A JP28068984A JPH0456807B2 JP H0456807 B2 JPH0456807 B2 JP H0456807B2 JP 59280689 A JP59280689 A JP 59280689A JP 28068984 A JP28068984 A JP 28068984A JP H0456807 B2 JPH0456807 B2 JP H0456807B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- reaction
- physiologically active
- agarose
- insoluble polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229920000642 polymer Polymers 0.000 claims description 24
- 239000013543 active substance Substances 0.000 claims description 17
- 125000003700 epoxy group Chemical group 0.000 claims description 16
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 claims description 15
- 125000003277 amino group Chemical group 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
- 230000003647 oxidation Effects 0.000 claims description 10
- 238000007254 oxidation reaction Methods 0.000 claims description 10
- 150000002016 disaccharides Chemical class 0.000 claims description 9
- 150000002009 diols Chemical group 0.000 claims description 8
- 125000003172 aldehyde group Chemical group 0.000 claims description 7
- 150000002772 monosaccharides Chemical class 0.000 claims description 7
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 claims description 6
- 239000012279 sodium borohydride Substances 0.000 claims description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 5
- 238000007248 oxidative elimination reaction Methods 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000000376 reactant Substances 0.000 claims description 2
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 22
- 229920000936 Agarose Polymers 0.000 description 19
- 238000000034 method Methods 0.000 description 16
- 239000003446 ligand Substances 0.000 description 13
- 125000006850 spacer group Chemical group 0.000 description 13
- 239000000203 mixture Substances 0.000 description 11
- 239000011521 glass Substances 0.000 description 10
- 239000000969 carrier Substances 0.000 description 9
- 238000001179 sorption measurement Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 229920001577 copolymer Polymers 0.000 description 8
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 8
- 239000011543 agarose gel Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 230000003100 immobilizing effect Effects 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 150000001299 aldehydes Chemical class 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- -1 polysaccharide periodate Chemical class 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000004593 Epoxy Substances 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 108090001090 Lectins Proteins 0.000 description 3
- 102000004856 Lectins Human genes 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000035 biogenic effect Effects 0.000 description 3
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000002523 lectin Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 2
- 102000012289 Corticotropin-Releasing Hormone Human genes 0.000 description 2
- 108010022152 Corticotropin-Releasing Hormone Proteins 0.000 description 2
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 239000002262 Schiff base Substances 0.000 description 2
- 150000004753 Schiff bases Chemical class 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000006735 epoxidation reaction Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical group NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 108010062580 Concanavalin A Proteins 0.000 description 1
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000002397 Kinins Human genes 0.000 description 1
- 108010093008 Kinins Proteins 0.000 description 1
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 102000007982 Phosphoproteins Human genes 0.000 description 1
- 108010089430 Phosphoproteins Proteins 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 150000001312 aldohexoses Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 150000008195 galaktosides Chemical class 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000008146 mannosides Chemical class 0.000 description 1
- HOVAGTYPODGVJG-VEIUFWFVSA-N methyl alpha-D-mannoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O HOVAGTYPODGVJG-VEIUFWFVSA-N 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920002454 poly(glycidyl methacrylate) polymer Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 108010048090 soybean lectin Proteins 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Description
ãç£æ¥äžã®å©çšåéã
æ¬çºæã¯å®å®ã§ããã€ãéç¹ç°çåžçãå°ãª
ãã芪氎æ§ã®ã¹ããŒãµãŒãæããããã«ãé«ããª
ã¬ã³ãïŒç®çç©è³ªãšã¢ãã€ããã€ãŒãæããç©
è³ªïŒæ¿åºŠãæããççæŽ»æ§ç©è³ªã®è£œé æ³ã«é¢ã
ãã
ãªã¬ã³ããšããŠã¯ãã¿ã³ãã¯è³ªããããããã¢
ããé
žãããã³çäœã¢ãã³çããã¹ãŠã®ã¢ããåº
ãæããççæŽ»æ§ç©è³ªã«é©å¿ãããã
ãåŸæ¥ã®æè¡ã
åŸæ¥ãåºå®åççæŽ»æ§ç©è³ªã補é ããããã«çš
ããããåºå®åçšé«ååæ
äœãšããŠã¯ãéç¹ç°ç
åžçããªããæŽ»æ§åããããå®èœåºãæãããã®
ã奜é©ãšãããŠããã
ç¹ã«ãã¢ãã€ããã€ãŒåžçå€ãšããŠäœ¿çšããå Ž
åã¯ãå€åæ§ã§åžç容éã倧ããã§ããç©ççã
ååŠçã«å®å®ã§ãçç¶æåãããé«ååæ
äœã奜
ãŸããããã®ãããªé«ååæ
äœãšããŠã¢ã¬ããŒã¹
ã²ã«ãããªããã«ã¢ã«ã³ãŒã«ç³»æš¹èçãå®çšåã
ããŠããã
ãçºæã解決ããããšããåé¡ç¹ã
å
±æçµåã«ããåºå®åæ¹æ³ãšããŠèåã·ã¢ã³ã
çšããæ¹æ³ããããNatureã第215å·»ã1491ã
1492é ïŒ1967幎ïŒãã
ãã®æ¹æ³ã¯ãåå¿ã¹ããããçãã容æã«èª¿è£œ
ã§ãããããã¢ããåºããªã³é
žåºã®åºå®åã«æ±çš
ãããŠããããåé¢ã掻æ§åã«äœ¿çšããèåã·
ã¢ã³ãææ¯ã§ãããã¢ããåºãšã«ãããªã³ã°ã
ãå Žåãæ¶æ©éšã圢æããŠããã€ãœãŠã¬ã¢çµåã¯
äžå®å®ã§ãã¢ãã€ããã€ãŒã¯ãããã°ã©ãã€ãŒã
è¡ãç·©è¡æ¶²ãã¢ã«ã«ãªæ§ã«ãªããšãåºå®åããã
ãªã¬ã³ããæŒåºããŠããå±éºæ§ããããã€ãã
åºã®PKaãçŽ10ã§ããã®ã§ãäžæ§ä»è¿ã«ãããŠ
ã¯éœé»è·ããã€ãããéç¹ç°çåžçãèµ·ããããš
ããæ¬ ç¹ãæããã
ã¢ããåºãæããç©è³ªãåºå®åããæ¹æ³ãšã
ãŠãå€ç³é¡ã®éãšãŠçŽ é
žé
žåæ³ããã
ãImmunologyã第20å·»ã1061ã1065é ïŒ1971
幎ïŒããããã¯ãå€ç³é¡ã®æ§æç³æ®åºã®ãžãªãŒã«æ§
é ãéãšãŠçŽ é
žé
žåããé
žåéè£ã«ããçæãã
ã¢ã«ãããåºã«ã¢ããåºãåå¿ãããããã«ãæ°Ž
çŽ åããŠçŽ ãããªãŠã ã§éå
ããäžæº¶æ§åºå®åç©
質ãäœãæ¹æ³ã§ããã
ãããããã®æ¹æ³ã§ã¯ãã¹ããŒãµãŒïŒãªã¬ã³
ããšæ
äœã®éã«å°å
¥ããä»»æã®é·ãã®ååïŒãå°
å
¥ã§ããªãããªã¬ã³ãæ¿åºŠãäœãããšããã¢ã
ã€ããã€ãŒåžçäœãšããŠã¯æ±ºå®çæ¬ é¥ãæããã
ãåé¡ç¹ã解決ããããã®ææ®µã
æ¬çºæã¯ãåè¿°ã®èåã·ã¢ã³æ³ãå€ç³é¡ã®éãš
ãŠçŽ é
žé
žåæ³çã®æ¬ ç¹ã倧å¹
ã«æ¹è¯ãããã®ã§ã
ãšããã·åºãæããäžæº¶æ§é«ååæ
äœãããã¯ãš
ããã·åºãæããã¹ããŒãµãŒãå°å
¥ããæ°Žé
žåºã
ã¢ããåºãã«ã«ããã·ã«åºããŸãã¯ïŒããã³ã¢ã
ãåºãæã€äžæº¶æ§é«ååæ
äœããã¢ã«ã«ãªæ§äž
ã§ãïŒçŽæ°Žé
žåºãšéãšãŠçŽ é
žé
žåã«ããéè£å¯èœ
ãªãžãªãŒã«åºãæããåç³ãŸãã¯ïŒç³ãšåå¿ã
ããåŸãããç³çµåäžæº¶æ§é«ååãéãšãŠçŽ é
žã«
ãŠé
žåéè£ããããšã«ããçããã¢ã«ãããåº
ã«ãã¢ããåºãæããççæŽ»æ§ç©è³ªãåå¿ããã
äž¡è
ã®éã«ã·ããå¡©åºã圢æãããŠåºå®åããã
ãã«èŠããã°ããã®åå¿ç©ãéåžžè¡ãããŠããæ°Ž
çŽ åããŠçŽ ãããªãŠã ãŸãã¯ã·ã¢ãæ°ŽçŽ åããŠçŽ
ãããªãŠã ã§éå
ããæ¹æ³ã«ãã€ãŠçµåãå®å®å
ãããã®ã§ããã
æ¬çºææ¹æ³ã«ãããŠäœ¿çšãããšããã·åºãæã
ãäžæº¶æ§é«ååãšããŠã¯ãäºããšããã·åºãæã
ããããã¯ååŠåå¿ã«ãã€ãŠãšããã·åºãå°å
¥ã
æ°Žã«äžæº¶ã§å®å®ãªããªããŒã§ããã°ãããã§ãã
ãã
ãšããã·åºãæããäžæº¶æ§é«ååæ
äœã®äŸãšã
ãŠã¯ãããªã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒããŸãã¯ãã®
å
±éåäœããã³ãšããã·æš¹èçãããããããã®
æ
äœã䜿çšããå Žåã¯ããã®ãŸãŸã®ç¶æ
ã§åå¿ã«
äŸããããŸããæ°Žé
žåºãæããäžæº¶æ§é«ååæ
äœ
ã®äŸãšããŠã¯ãã¢ã¬ããŒã¹ãããªããã«ã¢ã«ã³ãŒ
ã«ç³»æš¹èãããããã·ãšãã«ïŒãŸãã¯ã¡ãã«ïŒã¢
ã¯ãªã¬ãŒããŸãã¯ãã®å
±éåäœãããããã·ãšã
ã«ïŒãŸãã¯ã¡ãã«ïŒã¡ã¿ã¯ãªã¬ãŒããŸãã¯ãã®å
±
éåäœãâã¡ãããŒã«ã¢ã¯ãªã«ã¢ãããŸãã¯ã
ã®å
±éåäœçããããã¢ããåºãæããäžæº¶æ§é«
ååæ
äœã®äŸãšããŠã¯ãã¢ãããšãã«ã¢ã¬ããŒ
ã¹ãã¢ããããã·ã«ã¢ã¬ããŒã¹ãã¢ãããšãã«ã
ãªã¢ã¯ãªã«ã¢ããçããããã«ã«ããã·ã«åºãæ
ããäžæº¶æ§é«ååæ
äœã®äŸãšããŠã¯ããã¬ã€ã³é
ž
ã®ããªããŒãŸãã¯ãã®å
±éåäœãã¢ã¯ãªã«é
žã®ã
ãªããŒãŸãã¯ãã®å
±éåäœãã¡ã¿ã¯ãªã«é
žã®ããª
ããŒãŸãã¯ãã®å
±éåäœãã€ã¿ã³ã³é
žã®ããªããŒ
ãŸãã¯ãã®å
±éåäœçããããã¢ããåºãæãã
äžæº¶æ§é«ååæ
äœã®äŸãšããŠã¯ãããªã¢ã¯ãªã«ã¢
ããç³»ããªããŒçããããããããã®æ
äœã䜿çš
ããå Žåã¯ãæ¢ç¥ã®æ¹æ³ã«ãããšãã¯ãã«ãããª
ã³ããšãããã ãããªã³çã®ãšããããããªã³ãŸ
ãã¯ãã¹ãªãã·ã©ã³ååç©ãçšããŠãšããã·åºã
å°å
¥ããåŸãåå¿ã«äŸããããšãå¿
èŠã§ããã
ç³çµåäžæº¶æ§é«ååæ
äœã®äœæã¯ãåžåŒæ¿Ÿéã
ããšããã·åºãæããæ
äœã«ã該æ
äœïŒïœåœãã
ã¢ã«ã«ãªæ°Žæº¶æ¶²ïŒPH11ã13ïŒãïŒã50mlæ·»å ãã
åŸãïŒçŽæ°Žé
žåºãšéãšãŠçŽ é
žé
žåã«ããéè£å¯èœ
ãªãžãªãŒã«åºãæããåç³ãŸãã¯ïŒç³ãæ·»å ãã
20âã40âã§æ¯çªãããåå¿æéã¯ïŒã30æéã
奜ãŸããã
æ·»å ããåç³ãŸãã¯ïŒç³ã¯ãšããã·åºããšãã
ã·åºã®éã¯L.SundbergãïŒJ.Chromatogr.ïŒç¬¬90
å·»ã87ã98é ã1974幎ïŒã®æ¹æ³ã«ããæž¬å®ãã®ã¢
ã«æ°ã«å¯ŸããŠ10ã50åã奜ãŸããã
çæããåç³ãŸãã¯ïŒç³çµåäžæº¶æ§é«ååæ
äœ
ã«ãããŠåç³ãŸãã¯ïŒç³ã¯ãšããã·åºãšäžçªåå¿
æ§ã®é«ã第ïŒã¢ã«ã³ãŒã«ã®æ°Žé
žåºãä»ããŠçµåã
ããã
æ¬çºææ¹æ³ã«ãããŠäœ¿çšããïŒçŽæ°Žé
žåºãšéãš
ãŠçŽ é
žé
žåã«ããéè£å¯èœãªãžãªãŒã«åºãšãæã
ãåç³ãšããŠã¯ãã°ã«ã³ãŒã¹ããã³ããŒã¹ãã¬ã©
ã¯ããŒã¹ãã¿ããŒã¹çã®ã¢ã«ããããœãŒã¹ãâ
ã¢ã»ãã«ã°ã«ã³ãµãã³ãâã¢ã»ãã«ã¬ã©ã¯ããµ
ãã³çã®ã¢ããç³çãããããŸããïŒçŽæ°Žé
žåºãš
éãšãŠçŽ é
žé
žåã«ããéè£å¯èœãªãžãªãŒã«åºãšã
æããïŒç³ãšããŠã¯ãã©ã¯ããŒã¹ããã«ããŒã¹ã
ã·ãšç³çãããã
åç³ãŸãã¯ïŒç³çµåäžæº¶æ§é«ååæ
äœã®é
žåé
è£ã¯ãéãšãŠçŽ é
žãŸãã¯ãã®å¡©ã奜ãŸããã¯0.04
ã0.2NéãšãŠçŽ é
žãããªãŠã 氎溶液ãåžåŒæ¿Ÿé
ããç³ãŸãã¯ïŒç³çµåäžæº¶æ§é«ååæ
äœã«ã該æ
äœïŒïœåœãïŒã100mlæ·»å ããïŒâã20âã30å
ãïŒæéãšããç¯å²å
ã§åå¿ãããŠè¡ãããšã奜
ãŸããã
ïŒçŽæ°Žé
žåºãšéãšãŠçŽ é
žé
žåã«ããéè£å¯èœãª
ãžãªãŒã«åºãæããåç³ãšããŠãã°ã«ã³ãŒã¹ãçš
ããå Žåã¯äž»ã«æ§é åŒãïŒãã®ã¹ããŒãµãŒãå°å
¥
ãããã
ïŒåŒäžãã¯äžæº¶æ§é«ååæ
äœã瀺ããããã¯
éãšãŠçŽ é
žãããªãŠã ã«ããé
žåéè£ããåæã
瀺ãã以äžã®åŒãåæ§ã§ãããïŒ
ä»ã«æ§é åŒãïŒããïŒããïŒããïŒãã®ã¹ããŒãµ
ãŒãå°å
¥ããããããããã®ã¹ããŒãµãŒãã¢ã«ã
ããåºãæããççæŽ»æ§ç©è³ªãåºå®åããå Žåæ
å¹ãšãªãã
ïŒçŽæ°Žé
žåºãšéãšãŠçŽ é
žé
žåã«ããéè£å¯èœãª
ãžãªãŒã«åºãæããïŒç³ãšããŠãã©ã¯ããŒã¹ãçš
ããå Žåã¯äž»ã«æ§é åŒãïŒãããïŒãã®ã¹ããŒãµãŒ
ãå°å
¥ãããã
ä»ã«ã°ã«ã³ãŒã¹ã®å Žåãšåæ§ãæ°çš®ã®ã¢ã«ãã
ãåºãæããã¹ããŒãµãŒãšé
žåéè£ãããªãç³ã
æããã¹ããŒãµãŒãå°å
¥ããããã¢ã«ãããåºã
æããã¹ããŒãµãŒã¯ççæŽ»æ§ç©è³ªãåºå®åããå Ž
åæå¹ã§ããããŸããç³ãæããã¹ããŒãµãŒã¯å®
å®ã§ãããã¢ãã€ããã€ãŒã¯ãããã°ã©ãã€ãŒã«
ãããŠäœã劚ããšãªããªãã
äžèšåå¿ã«ããåŸãããã¢ã«ãããæŽ»æ§åäžæº¶
æ§é«ååæ
äœãšã¿ã³ãã³è³ªããããããã¢ãã
é
žãããã³çäœã¢ãã³çã¢ããåºãæããççæŽ»
æ§ç©è³ªãåå¿ãããŠåºå®åããããšã«ãããåºå®
åççæŽ»æ§ç©è³ªãåŸãããšãã§ããã
ã¢ããåºãæããççæŽ»æ§ç©è³ªã®äŸãšããŠã¯ã
ã¬ã¯ãã³ããŠã·è¡æž
ã¢ã«ããã³ãγâã°ãããªã³
ïŒæäœïŒãé
µçŽ ããã€ãããã¯ãã³ããããã€ã³ïŒ¡
çã®ã¿ã³ãã¯è³ªãè²çŽ ã¿ã³ãã¯è³ªãç³ã¿ã³ãã¯
質ããªã³ã¿ã³ãã¯è³ªçã®è€åã¿ã³ãã¯è³ªããã
ã³ãå¯è
ç®è³ªåºæ¿ãã«ã¢ã³æŸåºå åïŒCRFïŒãã«
ã«ã·ããã³ãã°ã«ã«ãŽã³çã®ãããããçš®ã
ã®ã¢
ããé
žãããã³ãã¹ã¿ãã³ãããŒããããªãã¿ã
ã³çã®çäœã¢ãã³çãããã
ãã®æçšããæº¶åªãšããŠã¯ããªã³é
žç·©è¡æ¶²ãé
¢
é
žç·©è¡æ¶²çã®ç·©è¡æ¶²ã䜿çšããåºå®åãããçç
掻æ§ç©è³ªã®æŽ»æ§ãPHäŸåæ§ã®å Žåã¯é©å¿ããPH
ã§ãäžè¬ã®å Žåã¯PHïŒãPH10ã®ç¯å²å
ã§åå¿ãè¡
ãæ¹æ³ã奜ãŸããã
ççæŽ»æ§ç©è³ªã溶解ããç·©è¡æ¶²ã®éã¯ãåžåŒæ¿Ÿ
éããã¢ã«ãããæŽ»æ§åäžæº¶æ§é«ååæ
äœïŒïœåœ
ãïŒmlã10mlã®ç¯å²å
ã«ããããšã奜ãŸããã
åå¿æž©åºŠã¯åºå®åããççæŽ»æ§ç©è³ªã®æŽ»æ§å®å®
é åã§è¡ãã奜ãŸããã¯ïŒâã40âã§è¡ãã
åå¿æéã¯åºå®ååå¿éäžã®æ®åççæŽ»æ§ç©è³ª
éãæž¬å®ããããšã«ããæ±ºå®ãããããéåžžïŒæ
éã72æéã§ååã§ããã
äžèšåå¿åŸãã·ã¢ãããŠçŽ åæ°ŽçŽ ãããªãŠã ãŸ
ãã¯ããŠçŽ åæ°ŽçŽ ãããªãŠã ãæ·»å ããçæãã
ã·ããå¡©åºãéå
ãå®å®åããã
éå
å€ã«å¯ŸããŠäžå®å®ãªççæŽ»æ§ç©è³ªã®å Žå
ã¯ãã·ã¢ãããŠçŽ åæ°ŽçŽ ãããªãŠã ã䜿çšããæ¹
ã奜ãŸããã
éå
å€ã®éã¯åžåŒæ¿Ÿéæ
äœïŒïœåœã30mg以äžã
ãã°ååã§ãããéå
åå¿ã¯ïŒâã40âã®ç¯å²å
ã§ïŒã24æéåå¿ããã°ååã§ããã
åŸãããççæŽ»æ§ç©è³ªåºå®åäžæº¶æ§é«ååæ
äœ
ã«ã·ã¢ãããŠçŽ åãããªãŠã ãåžåŒæ¿Ÿéæ
äœïŒïœ
åœã30mg以äžå«ãä»»æéã®0.5ã2Mããªã¹âå¡©é
ž
ç·©è¡æ¶²ïŒPH7.4ïŒãå
¥ããïŒâã40âã®ç¯å²å
ã§
30åãïŒæéæŸçœ®ãããããã«ããæ
äœã«æ®åã
ãã¢ã«ãããåºãäžæŽ»æ§åºãžãšå°ã³ãããšãã§ã
ãã
以äžã®åå¿ã«ãã€ãŠé«æ¿åºŠã®ãªã¬ã³ãå°å
¥ãå¯
èœãšãªãããŸããéãšãŠçŽ é
žã®åå¿æ¡ä»¶ã倿Žã
ããããšã«ããããŸãã¯ãªã¬ã³ããšãªãççæŽ»æ§
ç©è³ªã®éã倿Žãããããšã«ãããèªç±ã«ãã®ãª
ã¬ã³ãæ¿åºŠã倿Žããããšãã§ãããåºå®ååç
ãçŽ90ïŒ
ãšããããŠããã
ãçºæã®å¹æã
æ¬çºææ¹æ³ã«ããã°ãåŸæ¥ã®ççæŽ»æ§ç©è³ªã®åº
å®åæ³ã®æ¬ ç¹ã倧å¹
ã«æ¹è¯ããããšãã§ãããã
ãªãã¡ãã¹ããŒãµãŒã«é¢ããŠã¯ãé»è·ãæã
ããéç¹ç°çåžçãå°ãªããå°å
¥ãããã¹ããŒ
ãµãŒã¯ååŠçã«å®å®ã§ãããèåã·ã¢ã³æ³ã«ã¿ã
ãããªã¬ã³ãã®æŒåºãå°ãªãã芪氎æ§ã®ã¹ãã³
ãµãŒãæãããçã®ç¹é·ãããã
ãŸãããªã¬ã³ãã«é¢ããŠã¯ãé«ããªã¬ã³ãæ¿
床ãåŸããããã€ãããªã¬ã³ãéã¯èªç±ã«å€æŽã§
ããããªã¬ã³ãã®åå¿åçãéåžžã«é«ããçã®
ç¹é·ãããã
ãã®ä»ã«ããšããã·åºã®å°å
¥ã«ãããæ¶æ©ã
圢æãããæ
äœã匷åãããŠãããæ
äœã«ç³ã
çµåããç¶æ
ã§é·æä¿åãã§ããåºå®ååå¿ãè¡
ãçŽåãéãšãŠçŽ é
žé
žé
žåãè¡ããåºå®åã«äŸã
ãããšãã§ããããšããç¹é·ãæããã
ã宿œäŸã
æ¬¡ã«æ¬çºæã®å®æœäŸã瀺ããæ¬çºæãããã«èª¬
æããã
宿œäŸ ïŒ
(1)ã°ã«ã³ãŒã¹åºå®åã¢ã¬ããŒã¹ã®èª¿è£œ
ã¢ã¬ããŒã¹ã²ã«ãšããŠããã«ãã·ã¢ç€Ÿã»ãã¢
ããŒã¹4Bãçšããã
ã°ã©ã¹ãã€ã«ã¿ãŒäžã§ãæ°Žã§ååã«æŽæµåŸããš
ããã·åã¯åžåŒæ¿Ÿéããã¢ã¬ããŒã¹ã²ã«30ïœã«50
ïŒ
ãžã¡ãã«ã¹ã«ããã·ã45mlã2M NaOH20mlã
ãšãã¯ãã«ãããªã³4.5mlãæ·»å ãã40âã§ïŒæ
鿝çªãããåå¿åŸãã°ã©ã¹ãã€ã«ã¿ãŒã«ç§»ãã
æ°Žã§ååã«æŽæµããŠãšããã·æŽ»æ§åã»ãã¢ããŒã¹
4BãåŸããå°å
¥ããããšããã·åºã¯Na2S2O3ã
䜿çšããL.Sundbengãã®æ¹æ³ã«ããæž¬å®ãããš
ãããåžåŒæ¿Ÿéã»ãã¢ããŒã¹4B1ïœåœãçŽ
40ÎŒmolã®ãšããã·åºãå°å
¥ãããã
ãã®ãšããã·æŽ»æ§åã¢ã¬ããŒã¹ã²ã«20ïœã«ã°ã«
ã³ãŒã¹ïŒïœã溶解ãã80mlã®0.1N NaOH溶液ã
æ·»å ãã37âã§20æéæ¯çªãããåå¿åŸãã°ã©ã¹
ãã€ã«ã¿ãŒäžã§ãæ°Žã§ååæŽæµããã°ã«ã³ãŒã¹çµ
åã¢ã¬ããŒã¹ãåŸãã
(2) ã¬ã¯ãã³ã®åºå®å
ã°ã«ã³ãŒã¹åºå®åã¢ã¬ããŒã¹15ïœã«0.1Néãš
ãŠçŽ é
žãããªãŠã 氎溶液150mlãå ããïŒâã§ïŒ
æéæ¯çªãããåå¿åŸãã°ã©ã¹ãã€ã«ã¿ãŒã«ç§»
ããé
žæ§æ°Žæº¶æ¶²ïŒPHïŒïŒã§ååã«æŽæµåŸããã«æ°Ž
ã§ååã«æŽæµããã¢ã«ãããæŽ»æ§åã¢ã¬ããŒã¹ã
åŸãã
ã¢ã«ãããæŽ»æ§åã¢ã¬ããŒã¹ïŒïœã«å¯Ÿããã³ã³
ã«ãããªã³ïŒ¡ïŒä»¥äžãConAããšããïŒã0.2Mαâ
ã¡ãã«ãã³ãã·ããå«ã0.1Mé
¢ç·©è¡æ¶²ïŒPH6.0ïŒ
10mlãæ·»å ãããConAéã¯58mgã110mgã156
mgã236mgããšå€ããïŒâã§48æéæ¯çªããã
åå¿åŸã忡件ã®ãã®ã«ã·ã¢ãããŠçŽ åæ°ŽçŽ ã
ããªãŠã ã100mgæ·»å ããããã«ãïŒâã§12æé
æ¯çªããã
åå¿ç©ãã°ã©ã¹ãã€ã«ã¿ãŒã«ç§»ãã0.1Mé
¢é
ž
ç·©è¡æ¶²ïŒPH6.0ïŒã§ååã«æŽæµããConAâã¢ã¬ã
ãŒã¹ããåŸãã
åŸãããConAâã¢ã¬ããŒã¹ïŒïœã«ã·ã¢ãããŠ
çŽ åæ°ŽçŽ ãããªãŠã 100mgãå«ã1Mããªã¹âå¡©é
ž
ç·©è¡æ¶²ïŒPH7.4ïŒ15mlãå ãã宀枩ã§ïŒæéæŸçœ®
åŸãã°ã©ã¹ãã€ã«ã¿ãŒäžã§ãæ°Žã§ååã«æŽæµã
ãã
åºå®åéã¯ããšã®ConAã®280nmã®åžå
åºŠãšæ®
åããŠããConAã®280nmã®åžå
床ã®å·®ããåºå®
åéãšããããã®çµæã衚ïŒã«ç€ºãã
[Industrial Application Field] The present invention is a bioactive substance that is stable, has little nonspecific adsorption, has a hydrophilic spacer, and has a high concentration of ligand (a substance that has affinity with the target substance). Regarding manufacturing methods. As a ligand, it is applicable to all physiologically active substances having an amino group, such as proteins, peptides, amino acids, and biogenic amines. [Prior Art] Conventionally, as a polymer carrier for immobilization used to produce an immobilized physiologically active substance, one that does not have non-specific adsorption and has a functional group that can be activated is considered suitable. . In particular, when used as an affinity adsorbent, the adsorption capacity can be increased due to the porosity, and the physical
A chemically stable, spherical polymeric carrier is preferred. Agarose gel, polyvinyl alcohol resin, and the like have been put into practical use as such polymer carriers. [Problems to be solved by the invention] There is a method of using cyanogen bromide as an immobilization method using covalent bonds [Nature, Vol. 215, 1491~
1492 pages (1967)]. This method is widely used for immobilizing amino groups and phosphate groups because the reaction steps are short and it can be easily prepared. In this case, the isourea bond forming the crosslinking part is unstable, and if the buffer used for affinity chromatography becomes alkaline, there is a risk that the immobilized ligand will leak out. is about 10, so it has a positive charge near neutrality, so it has the disadvantage of non-specific adsorption. Periodate oxidation of polysaccharides is a method for immobilizing substances with amino groups [Immunology, Vol. 20, pp. 1061-1065 (1971
Year)ã. This involves oxidizing the diol structure of the constituent sugar residues of polysaccharides with periodate, reacting the aldehyde group generated by oxidative cleavage with an amino group, and further reducing it with sodium borohydride to create an insoluble immobilized substance. It's a method. However, this method has decisive deficiencies as an affinity adsorbent in that a spacer (a molecule of arbitrary length to be introduced between the ligand and the carrier) cannot be introduced and the concentration of the ligand is low. [Means for Solving the Problems] The present invention significantly improves the drawbacks of the aforementioned cyanogen bromide method, polysaccharide periodate oxidation method, etc.
An insoluble polymer carrier having an epoxy group or a hydroxyl group introduced with a spacer having an epoxy group,
An insoluble polymer carrier having an amino group, a carboxyl group, or/and an amide group is reacted under alkaline conditions with a monosaccharide or disaccharide having a primary hydroxyl group and a diol group that can be cleaved by periodic acid oxidation. A physiologically active substance having an amino group is reacted with an aldehyde group generated by oxidative cleavage of a sugar-bonded insoluble polymer with periodic acid,
A Schiff base is formed between the two for immobilization, and if necessary, the bond is stabilized by reducing this reactant with commonly used sodium borohydride or sodium cyanoborohydride. It is. The insoluble polymer having an epoxy group used in the method of the present invention may be any water-insoluble and stable polymer that already has an epoxy group or into which an epoxy group has been introduced through a chemical reaction. Examples of insoluble polymer carriers having epoxy groups include polyglycidyl methacrylate or copolymers thereof, epoxy resins, etc. When these carriers are used, they are subjected to the reaction as they are. Examples of insoluble polymeric carriers having hydroxyl groups include agarose, polyvinyl alcohol resin, hydroxyethyl (or methyl) acrylate or its copolymer, hydroxyethyl (or methyl) methacrylate or its copolymer, N-methylol Examples of insoluble polymer carriers having amino groups include aminoethyl agarose, aminohexyl agarose, aminoethyl polyacrylamide, etc. Examples of insoluble polymer carriers having carboxyl groups include acrylamide or its copolymers, etc. There are polymers of maleic acid or copolymers thereof, polymers of acrylic acid or copolymers thereof, polymers of methacrylic acid or copolymers thereof, polymers of itaconic acid or copolymers thereof, etc., which are insoluble and have an amide group. Examples of polymeric carriers include polyacrylamide-based polymers, but when using these carriers, epoxy groups are introduced using epihalohydrin or bisoxirane compounds such as epichlorohydrin and epibromohydrin by known methods. After that, it is necessary to subject it to a reaction. To create a sugar-bonded insoluble polymer carrier, per 1 g of the carrier,
After adding 3 to 50 ml of an alkaline aqueous solution (PH 11 to 13), add a monosaccharide or disaccharide having a primary hydroxyl group and a diol group that can be cleaved by periodic acid oxidation,
Shake at 20°C to 40°C. The reaction time is preferably 5 to 30 hours. The monosaccharide or disaccharide to be added has an epoxy group [the amount of epoxy group is determined according to L. Sundberg et al. (J. Chromatogr., No. 90).
Vol. 87-98, 1974). In the produced monosaccharide- or disaccharide-bound insoluble polymer carrier, the monosaccharide or disaccharide is bound via the hydroxyl group of the primary alcohol, which is most reactive with the epoxy group. Monosaccharides having a primary hydroxyl group and a diol group cleavable by periodic acid oxidation used in the method of the present invention include aldohexoses such as glucose, mannose, galactose, and talose, N-
There are amino sugars such as acetylglucosamine and N-acetylgalactosamine, and disaccharides having a primary hydroxyl group and a diol group that can be cleaved by periodic acid oxidation include lactose, maltose,
There are sugar, etc. Oxidative cleavage of monosaccharide- or disaccharide-bound insoluble polymeric carriers is performed using periodic acid or its salts, preferably 0.04
Add 3 to 100 ml of ~0.2N sodium periodate aqueous solution per 1 g of the sugar- or disaccharide-bonded insoluble polymer carrier that has been suction-filtered, and react at 0°C to 20°C for 30 minutes to 5 hours. It is preferable to do so. When glucose is used as the monosaccharide having a primary hydroxyl group and a diol group that can be cleaved by periodic acid oxidation, a spacer of structural formula [1] is mainly introduced. (In the formula, G represents an insoluble polymer carrier, and ~ ~ represents a site that is oxidized and cleaved by sodium periodate. The same applies to the following formulas.) Other structural formulas [2] [3] [4] The spacer [5] is introduced, and all of the spacers have an aldehyde group and are effective when immobilizing a physiologically active substance. When lactose is used as a disaccharide having a primary hydroxyl group and a diol group that can be cleaved by periodic acid oxidation, spacers of structural formulas [6] and [7] are mainly introduced. In addition, as in the case of glucose, spacers with several types of aldehyde groups and spacers with sugars that are not oxidatively cleaved are introduced. A spacer having an aldehyde group is effective for immobilizing a physiologically active substance, and a spacer having a sugar is stable and does not interfere with affinity chromatography. Obtaining an immobilized physiologically active substance by reacting and immobilizing the aldehyde-activated insoluble polymer carrier obtained by the above reaction with a physiologically active substance having an amino group such as proteins, peptides, amino acids, and biogenic amines. I can do it. Examples of physiologically active substances having an amino group include:
Lectin, bovine serum albumin, γ-globulin (antibody), enzyme, fipronectin, protein A
complex proteins such as chromoproteins, glycoproteins, phosphoproteins, kinins, pupetides such as corticotropin-releasing factor (CRF), calcitonin, and glucagon, various amino acids, and biogenic amines such as histamine, dova, and tributamine. etc. The solvent used at this time is a buffer such as phosphate buffer or acetate buffer, and if the activity of the physiologically active substance to be immobilized is pH-dependent, the appropriate pH is used.
In general, it is preferable to carry out the reaction within the range of PH5 to PH10. The amount of the buffer solution in which the physiologically active substance is dissolved is preferably within the range of 2 ml to 10 ml per gram of the suction-filtered aldehyde-activated insoluble polymer carrier. The reaction temperature is set at a stable activity range of the physiologically active substance to be immobilized. Preferably it is carried out at 0°C to 40°C. The reaction time is determined by measuring the amount of physiologically active substance remaining during the immobilization reaction, and usually 5 to 72 hours is sufficient. After the above reaction, sodium cyanoborohydride or sodium borohydride is added to reduce and stabilize the generated Schiff base. In the case of physiologically active substances that are unstable to reducing agents, it is preferable to use sodium cyanoborohydride. It is sufficient that the amount of the reducing agent is 30 mg or more per gram of the suction filtration carrier, and it is sufficient that the reduction reaction is carried out at a temperature of 0°C to 40°C for 2 to 24 hours. Suction 1 g of sodium cyanoboride onto the obtained physiologically active substance-immobilized insoluble polymer carrier.
Add any amount of 0.5 to 2M Tris-HCl buffer (PH7.4) containing 30mg or more per bottle, and store at 0â to 40â.
Leave it for 30 minutes to 2 hours. This allows the aldehyde groups remaining on the carrier to become inert groups. The above reaction makes it possible to introduce a high concentration of the ligand, and by changing the reaction conditions of periodic acid or by changing the amount of the physiologically active substance serving as the ligand, the concentration of the ligand can be adjusted freely. Can be changed. The immobilization yield is also excellent at approximately 90%. [Effects of the Invention] According to the method of the present invention, the drawbacks of conventional methods for immobilizing physiologically active substances can be significantly improved. That is, regarding the spacer, it has no electric charge, has little non-specific adsorption, is chemically stable, has a hydrophilic spacer that causes less leakage of the ligand seen in the cyanogen bromide method, It has the following features. Further, regarding the ligand, there are advantages such as a high concentration of the ligand can be obtained, the amount of the ligand can be changed freely, and the reaction yield of the ligand is very high. In addition, by introducing epoxy groups, crosslinks are formed and the carrier is strengthened. It can be stored for a long time with sugar bound to the carrier. Immediately before the immobilization reaction, periodic acid oxidation is performed to immobilize It also has the advantage of being able to be used for various purposes. [Example] Next, Examples of the present invention will be shown to further explain the present invention. Example 1 (1) Preparation of glucose-immobilized agarose Fumarmacia Sepharose 4B was used as the agarose gel. After thoroughly washing with water on a glass filter, epoxidation was performed by adding 50 g of suction-filtered agarose gel.
% dimethyl sulfoxide 45ml, 2M NaOH20ml,
4.5 ml of epichlorohydrin was added and the mixture was shaken at 40°C for 2 hours. After the reaction, transfer to a glass filter,
Epoxy-activated Cephalose by washing thoroughly with water.
Got 4B. The introduced epoxy group was measured by the method of L. Sundbeng et al. using Na 2 S 2 O 3 and was found to be approximately
40 Όmol of epoxy groups were introduced. To 20 g of this epoxy-activated agarose gel was added 80 ml of a 0.1N NaOH solution in which 3 g of glucose was dissolved, and the mixture was shaken at 37° C. for 20 hours. After the reaction, the mixture was thoroughly washed with water on a glass filter to obtain glucose-bonded agarose. (2) Immobilization of lectin Add 150 ml of 0.1N sodium periodate aqueous solution to 15 g of glucose-immobilized agarose, and
Shake for hours. After the reaction, the mixture was transferred to a glass filter, thoroughly washed with an acidic aqueous solution (PH3), and then thoroughly washed with water to obtain aldehyde-activated agarose. Concanavalin A (hereinafter referred to as "ConA"), 0.2M α-
0.1M vinegar buffer containing methylmannoside (PH6.0)
Added 10ml. ConA amount is 58mg, 110mg, 156
mg, 236 mg, and shaken at 4°C for 48 hours. After the reaction, 100 mg of sodium cyanoborohydride was added to each condition, and the mixture was further shaken at 4°C for 12 hours. The reaction mixture was transferred to a glass filter and thoroughly washed with 0.1M acetate buffer (PH6.0) to obtain ConA-agarose. 15 ml of 1M Tris-HCl buffer (PH7.4) containing 100 mg of sodium cyanoborohydride was added to 3 g of the obtained ConA-agarose, and after being left at room temperature for 1 hour, it was thoroughly washed with water on a glass filter. The amount of immobilization was determined from the difference between the absorbance of the original ConA at 280 nm and the absorbance of the remaining ConA at 280 nm. The results are shown in Table 1.
ã衚ã
åºå®åéã¯ConAã§ç€ºããéããåå¿ã«äœ¿çšãã
ã¬ã¯ãã³éã倿Žããã°ãããã«å¿ããŠåºå®åé
ã®å€æŽãå¯èœããã
åŸãããåºå®åConAâã¢ã¬ããŒã¹ã«ã€ããŠåº
å®åãããConAãšçžäºäœçšãæãããã©ã¢ãã
ããšãã«ãã³ãã·ããçšããŠåžç容éãå端åæ
ã«ããæ€å®ããã
ã²ã«ã¯ïŒmlãã«ã©ã ïŒçŽåŸïŒmmÃé·ãïŒcmïŒã
ã䜿çšãã察ç
§ãšããŠConAãšçžäºäœçšãæããª
ããã©ã¢ããããšãã«ã¬ã©ã¯ãã·ãã䜿çšããã
ãã®çµæã衚ïŒã«ç€ºãã[Table] As shown in ConA, by changing the amount of lectin used in the reaction, the amount of immobilization can be changed accordingly. The adsorption capacity of the obtained immobilized ConA-agarose was tested by front-end analysis using para-aminophenyl mannoside that interacts with immobilized ConA. 1 ml of gel [column (diameter 4 mm x length 8 cm)]
was used, and para-aminophenyl galactoside, which has no interaction with ConA, was used as a control.
The results are shown in Table 2.
ã衚ã
ããã«ããã€ãã³ããŒã¹ã¿ã€ãã®ç³éãæãã
倧è±ã¬ã¯ãã³ïŒä»¥äžãSBAããšããïŒãçšããŠ
åžçéãæ€å®ãããConAâã¢ã¬ããŒã¹ïŒmlïŒ18
mgConAïŒmlã²ã«ïŒåœãSBAã34mgåžçãããã
åºå®åConAã¢ã¬ããŒã¹ã¯ååãªåžçèœåãæ
ããããããã䜿çšã«ãã€ãŠãåžçèœã®äœäžã¯èŠ
ãããªãã€ãã
宿œäŸ ïŒ
(1) ã©ã¯ããŒã¹åºå®åã¢ã¬ããŒã¹ã®èª¿è£œ
ã¢ã¬ããŒã¹ã²ã«ãšããŠãã¢ã«ãã·ã¢ç€Ÿã»ãã¢ã
ãŒã¹4Bãçšããã
ã°ã©ã¹ãã€ã«ã¿ãŒäžã§ãæ°Žã§ååã«æŽæµåŸããš
ããã·åã¯åžåŒæ¿Ÿéããã¢ã¬ããŒã¹ã²ã«30ïœã«50
ïŒ
ãžã¡ãã«ã¹ã«ããã·ã45mlã2M NaOH20mlã
ãšãã¯ãã«ãããªã³4.5mlãæ·»å ãã40âã§ïŒæ
鿝çªãããåå¿åŸãã°ã©ã¹ãã€ã«ã¿ãŒã«ç§»ãã
æ°Žã§ååã«æŽæµããŠãšããã·æŽ»æ§åã»ãã¢ããŒã¹
4BãåŸããå°å
¥ããããšããã·åºã¯Na2S2O3ã
䜿çšããL.Sundbengãã®æ¹æ³ã«ããæž¬å®ããã
åžåŒæ¿Ÿéã»ãã¢ããŒã¹4B1ïœåœãçŽ40ÎŒmolã®ãš
ããã·åºãå°å
¥ãããã
ãã®ãšããã·æŽ»æ§åã¢ã¬ããŒã¹ã²ã«20ïœã«ã©ã¯
ããŒã¹ïŒïœã溶解ãã80mlã®0.1N NaOH溶液ã
æ·»å ãã37âã§20æéæ¯çªãããåå¿åŸãã°ã©ã¹
ãã€ã«ã¿ãŒäžã§ãæ°Žã§ååæŽæµããã©ã¯ããŒã¹çµ
åã¢ã¬ããŒã¹ãåŸãã
(2)çè¡æž
ã¢ã«ããã³ïŒä»¥äžãBSAããšããïŒã®
åºå®å
ã©ã¯ããŒã¹åºå®åã¢ã¬ããŒã¹15ïœã«0.1Néãš
ãŠçŽ é
žãããªãŠã 氎溶液150mlãå ããïŒâã§ïŒ
æéæ¯çªãããåå¿åŸããã°ã©ã¹ãã€ã«ã¿ãŒã«ç§»
ããé
žæ§æ°Žæº¶æ¶²ïŒPHïŒïŒã§ååã«æŽæµåŸãããã«
æ°Žã§ååã«æŽæµããã¢ã«ãããæŽ»æ§åã¢ã¬ããŒã¹
ãåŸãã
ã¢ã«ãããæŽ»æ§åã¢ã¬ããŒã¹ïŒïœã«BSA250mg
ãæº¶è§£ãã0.1Mãªã³é
žç·©è¡æ¶²ïŒPH7.2ïŒ10mlãå
ãã25âã§24æéæ¯çªããããã®åŸãããŠçŽ åæ°Ž
çŽ ãããªãŠã 90mgãå ããïŒæéæ¯çªãããåå¿
çµäºåŸãäžæž
ãé€ã0.1Mãªã³é
žç·©è¡æ¶²ã§ååã«
æŽæµããåºå®åBSAã¢ã¬ããŒã¹ãåŸããåºå®å
éã¯ConAãšåæ§280nmã®åžå
床ã®å·®ããæ±ã
ãã
ãã®çµæã宿œäŸïŒã®åºå®åConAãšäœµããŠè¡š
ïŒã«ç€ºãã
ãªããåèãŸã§ã«ãã¢ã¬ããŒã¹ãçŽæ¥éãšãŠçŽ
é
žé
žåããåŸæ¥æ³ãMethods in Enzymologyã
38å·»ãPartBã82é ã1974ïŒãã«ããã¢ã«ããã³
ã®åºå®åéã䜵èšããã[Table] Furthermore, the amount of adsorption was assayed using soybean lectin (hereinafter referred to as "SBA") having a high mannose type sugar chain. ConA-Agarose 1 ml (18
34mg of SBA was adsorbed per mgConA/ml gel). The immobilized ConA agarose had sufficient adsorption capacity, and no decrease in adsorption capacity was observed even after repeated use. Example 2 (1) Preparation of lactose-immobilized agarose Sepharose 4B manufactured by Pharmacia Co., Ltd. was used as the agarose gel. After thoroughly washing with water on a glass filter, epoxidation was performed by adding 50 g of suction-filtered agarose gel.
% dimethyl sulfoxide 45ml, 2M NaOH20ml,
4.5 ml of epichlorohydrin was added and the mixture was shaken at 40°C for 2 hours. After the reaction, transfer to a glass filter,
Epoxy-activated Cephalose by washing thoroughly with water.
Got 4B. The introduced epoxy group was measured by the method of L. Sundbeng et al. using Na 2 S 2 O 3 .
Approximately 40 Όmol of epoxy groups were introduced per gram of suction-filtered Sepharose 4B. 80 ml of a 0.1N NaOH solution containing 6 g of lactose was added to 20 g of this epoxy-activated agarose gel, and the mixture was shaken at 37° C. for 20 hours. After the reaction, the mixture was thoroughly washed with water on a glass filter to obtain lactose-bonded agarose. (2) Immobilization of bovine serum albumin (hereinafter referred to as "BSA") Add 150 ml of 0.1N sodium periodate aqueous solution to 15 g of lactose-immobilized agarose, and
Shake for an hour. After the reaction, the mixture was transferred to a glass filter, thoroughly washed with an acidic aqueous solution (PH3), and then thoroughly washed with water to obtain aldehyde-activated agarose. 3g of aldehyde-activated agarose and 250mg of BSA
10 ml of 0.1M phosphate buffer (PH7.2) in which 20% was dissolved was added, and the mixture was shaken at 25°C for 24 hours. Thereafter, 90 mg of sodium borohydride was added and the mixture was shaken for 1 hour. After the reaction was completed, the supernatant was removed and thoroughly washed with 0.1M phosphate buffer to obtain immobilized BSA agarose. The amount of immobilization was determined from the difference in absorbance at 280 nm, similar to ConA. The results are shown in Table 3 together with the immobilized ConA of Example 1. For reference, the conventional method of directly oxidizing agarose with periodate [Methods in Enzymology,
38, Part B, p. 82, 1974)] is also shown.
Claims (1)
ãªæ§ã®æ¡ä»¶äžã§ãïŒçŽæ°Žé žåºãšéãšãŠçŽ é žé žåã«
ããéè£å¯èœãªãžãªãŒã«åºãšãæããåç³ãŸãã¯
ïŒç³ãšåå¿ãããåŸãããç³çµåäžæº¶äœé«ååã
éãšãŠçŽ é žã«ãŠé žåéè£ããããšã«ããçããã¢
ã«ãããåºã«ãã¢ããåºãæããççæŽ»æ§ç©è³ªã
åå¿ãããŠåºå®åããããã«èŠããã°ããã®åå¿
ç©ãæ°ŽçŽ åããŠçŽ ãããªãŠã ãã·ã¢ãæ°ŽçŽ åããŠ
çŽ ãããªãŠã ã§éå ããŠçµåãå®å®åããããšã
ç¹åŸŽãšããåºå®åççæŽ»æ§ç©è³ªã®è£œé æ³ã1. A sugar-bonded insoluble polymer obtained by reacting an insoluble polymer having an epoxy group with a monosaccharide or disaccharide having a primary hydroxyl group and a diol group that can be cleaved by periodic acid oxidation under alkaline conditions. A physiologically active substance having an amino group is reacted with the aldehyde group produced by the oxidative cleavage of the compound with periodic acid to immobilize it, and if necessary, this reactant is treated with sodium borohydride or sodium cyanoborohydride. A method for producing an immobilized physiologically active substance, characterized by stabilizing the bond by reduction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59280689A JPS61152634A (en) | 1984-12-27 | 1984-12-27 | Production of immobilized physiologically active substance |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59280689A JPS61152634A (en) | 1984-12-27 | 1984-12-27 | Production of immobilized physiologically active substance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61152634A JPS61152634A (en) | 1986-07-11 |
| JPH0456807B2 true JPH0456807B2 (en) | 1992-09-09 |
Family
ID=17628566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59280689A Granted JPS61152634A (en) | 1984-12-27 | 1984-12-27 | Production of immobilized physiologically active substance |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61152634A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62155300A (en) * | 1985-12-27 | 1987-07-10 | Sugiyama Sangyo Kagaku Kenkyusho | Production of immobilized physiologically active substance |
| DE69225542T2 (en) * | 1991-02-21 | 1998-09-10 | Drug Delivery System Inst Ltd | CARBOXYMETHYLMANNOGLUKAN AND DERIVATIVES THEREOF |
-
1984
- 1984-12-27 JP JP59280689A patent/JPS61152634A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61152634A (en) | 1986-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3645852A (en) | Method of binding water-soluble proteins and water-soluble peptides to water-insoluble polymers using cyanogen halide | |
| US5092992A (en) | Polyethyleneimine matrixes for affinity chromatography | |
| US6699386B2 (en) | Endotoxin adsorbent, and a method of removing endotoxin by using the same | |
| JPS6159175B2 (en) | ||
| JPH037681B2 (en) | ||
| US5085779A (en) | Polyethyleneimine matrixes for affinity chromatography | |
| JPS61272202A (en) | Production of material for affinity chromatography | |
| JPH051714B2 (en) | ||
| JP2002119854A (en) | Separating material for stimulus response type affinity chromatography material and separating and refining method | |
| EP0431220A1 (en) | Method of making a sulfonate ester and cross-linked alcohol coated support matrix | |
| JPS6133557B2 (en) | ||
| JPS5853757A (en) | Adsorbent for immuno-affinity chromatography and manufacture of same | |
| EP0153763B1 (en) | Affinity chromatography matrix with built-in reaction indicator | |
| JPH0456807B2 (en) | ||
| DE2102514A1 (en) | Process for the chemical coupling of biologically active substances to polymers containing oxirane | |
| Scouten | Matrices and activation methods for cell adhesion/immobilization studies | |
| EP0403700B1 (en) | Polyethyleneimine matrixes for affinity chromatography | |
| CN102580683B (en) | Endotoxin synergistic adsorbent and preparation method thereof | |
| US4775714A (en) | Method for producing highly-active biologically active compounds immobilized on a carrier | |
| JPS59204601A (en) | Manufacture of molded article having physiological activity | |
| JPS62155300A (en) | Production of immobilized physiologically active substance | |
| JPH05261281A (en) | Carrier for immobilizing bioactive substance and its production | |
| JPH0518950A (en) | Attraction carrier for affinity chromatography | |
| JPH0359080B2 (en) | ||
| JPS60202737A (en) | Manufacture of affinity adsorbent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |